Results 221 to 230 of about 346,610 (333)
Anticoagulant management in an antithrombin-deficient pregnant woman with a history of venous thromboembolism: a case report. [PDF]
Kozak M +6 more
europepmc +1 more source
Anticoagulants and Arteriosclerosis [PDF]
openaire +3 more sources
Milvexian, an activated factor XI inhibitor, is being evaluated in the LIBREXIA phase III program for the prevention of thrombotic events, including in patients with atrial fibrillation (LIBREXIA AF). To guide the selection of a phase III dose regimen for LIBREXIA AF, two main approaches were used: (1) population pharmacokinetics and exposure–response ...
Wangda Zhou +12 more
wiley +1 more source
Spontaneous Retroperitoneal Hematoma in SARS-CoV-2 Patients: Diagnostic and Management Challenges-A Literature Review. [PDF]
Sandu A +4 more
europepmc +1 more source
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are widely used for pain and inflammation but are associated with gastrointestinal (GI) bleeding. While this risk is well established, most studies evaluate NSAIDs as a homogenous class, limiting clinical decision‐making based on individual agent safety.
Abdelrahman G. Tawfik +7 more
wiley +1 more source
Efficacy and safety of naphlimostat mesylate versus sodium citrate in CRRT for EICU patients with coagulation dysfunction: A STROBE-compliant observational study. [PDF]
Song B, Liu C, Fu K.
europepmc +1 more source
Studies on the Nature of the Circulating Anticoagulant Directed against Antihemophilic Factor: With Notes on an Assay for Antihemophilic Factor [PDF]
Robert T. Breckenridge, Oscar D. Ratnoff
openalex +1 more source

